Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04847895 Completed - Clinical trials for Neovascular (Wet) Age-related Macular Degeneration

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

PACIFIC
Start date: June 1, 2015
Phase:
Study type: Observational

This study is designed as an observational, non-interventional, multicenter, open label, single arm study in patients being treated with Lucentis® for any approved indication included in the local product posology.

NCT ID: NCT04847427 Completed - Control Condition Clinical Trials

Recovery Kinetics After Different Power Training Protocols (PTRecovery)

PTRecovery
Start date: April 20, 2021
Phase: N/A
Study type: Interventional

Muscle power is one of the most important parameters in almost every athletic action, expressing the ability of the human muscle to produce great amounts of force with the greatest possible speed. For enhancing their muscle power, athletes comprise several resistance training programs as part of their training. However, muscle power training comprises of eccentric muscle actions, which, especially when unaccustomed, can lead to exercise-induced muscle damage and deterioration of muscle performance. Nevertheless, despite the fact that muscle power training comprises eccentric muscle actions, and consequently can lead to muscle injury and muscle performance reduction during the following days, the recovery kinetics after acute muscle power training have not been adequately studied. However, information regarding the recovery of the muscles after a power training protocol, is critical for the correct design of a training microcycle, and the reduction of injury risk. The aim of the present study is to investigate the muscle injury provoked after acute muscle power training using three different power training exercise protocols. Additionally, the effect of these protocols on muscle performance and neuromuscular fatigue indices will be examined.

NCT ID: NCT04846647 Completed - Clinical trials for Unexplained Hypophosphatemia

Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of Hypophosphatemia

IFEH
Start date: October 5, 2021
Phase:
Study type: Observational

The discovery of FGF23, the missing link in the long researched and finally found phosphate metabolism, marked a turning point in the understanding and physiopathology of specific hypophosphatemia. By inhibiting the renal reabsorption of phosphate and the production of calcitriol, FGF23 behaves like a hypophosphatemia hormone. Hypersecretion of FGF23 can occur in the case of genetic abnormalities (X-linked hypophosphatemic vitamin-resistant rickets, recessive or dominant hypophosphatemic rickets, McCune-Albright syndrome ...) or acquired abnormalities (oncogenic osteomalacia). Oncogenic osteomalacia can be induced by hyperproduction of FGF23 by benign tumours of mesenchymal origin. But more recently, several cases of malignant tumours secreting FGF23 have also been described (prostate, colon, breast, ovarian and lung cancers, pulmonary carcinoma, etc.)

NCT ID: NCT04845906 Completed - Clinical trials for Peripheral Intravenous Catheter Stabilization

A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

Start date: July 13, 2021
Phase:
Study type: Observational

This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.

NCT ID: NCT04845880 Completed - Clinical trials for SARS COV-2 IgG Levels on Health Workers

SARS Cov_2 Incidence of Healthy Health Workers

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Since the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) first emerged in Wuhan, China, on 12 December 2019, it has spread rapidly across the world and developed into a pandemic. The pandemic has affected over 100 countries and regions, with over 132 million confirmed cases of COVID-19. The rapid spread of SARS-CoV-2 has caused considerable harm to public health and the economy. Alongside other laboratory tests and clinical findings of the COVID-19 infection, serological testing may be beneficial for epidemiological monitoring and outbreak control. The determination of antibodies enables confirmation of the SARS-CoV-2 infection in asymptomatic patients in addition to those with typical symptoms. In this study, we aimed to determine the SARS-CoV-2 seroprevalence and the IgG antibody levels among healthcare workers who frequently encountered COVID-19 patients in our hospital.

NCT ID: NCT04845854 Completed - Clinical trials for Oral Complications of Chemotherapy and Head and Neck Radiation

Prevalence of Oral Side Effects Associated With Chemo and Radiotherapy for Treating Head and Neck Cancer

Start date: October 2, 2020
Phase:
Study type: Observational [Patient Registry]

A cross-sectional study will be conducted to report oral complications during chemo and radiotherapy treatment in case of patients diagnosed with head and neck cancer and the effect of theses oral side effects on patients' quality of life which will in turn allow the implication of preventive measures

NCT ID: NCT04845815 Completed - Clinical trials for Renal Tubular Disorders in Children

Renal Tubular Disorders in Egyptian Children

Start date: April 23, 2021
Phase:
Study type: Observational [Patient Registry]

Renal tubules play an important role in fluid, electrolyte, and acid-base homeostasis. Defect of these functions can give rise to a host of disorders. These disorders can lead to life threatening disturbances in electrolytes and acid-base balance. In Egypt, there is little data about these disorders. Many of these cases are diagnosed late, therefore Early suspicion for diagnosis can improve the overall clinical outcome of these children.

NCT ID: NCT04845048 Completed - Clinical trials for SARS-CoV-2 Acute Respiratory Disease

Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine

Start date: May 10, 2021
Phase:
Study type: Observational

This is a prospective cohort study, observational, multicentre, single-arm, post-registration to assess the safety of the Adsorbed COVID-19 (Inactivated) Vaccine Sinovac / Institute Butantan.

NCT ID: NCT04845009 Completed - Clinical trials for Progressive Muscle Relaxation on Postoperative Pain, Fatigue, and Vital Signs in Patients With Head and Neck Cancers

Relaxation Therapy for Pain, Fatigue and Vital Signs in Post-operation With Head and Neck Cancer

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

This study aimed to investigate the effects of progressive muscle relaxation (PMR) on postoperative pain, fatigue, and vital signs in patients with head and neck cancers.

NCT ID: NCT04844892 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Phrenic Nerve Stimulation-Induced Lung ReAeration Trial

PIRAT
Start date: August 25, 2021
Phase: N/A
Study type: Interventional

The Lungpacer PROTECT Diaphragm Pacing Therapy System (DPTS) is a temporary, percutaneously-placed, transvenous, phrenic nerve-stimulating device intended to stimulate the diaphragm to preserve and improve inspiratory muscle strength in mechanically ventilated patients. The purpose of the PROTECT DPTS is to improve gas exchange, regional lung ventilation, and hemodynamics, and decrease atelectasis in patients presenting with acute respiratory distress syndrome (ARDS).